StockWatch
·

Venmax Drugs And Pharmaceuticals Ltd Q4 FY26 Results

VENMAXQ4 FY26 Results
Filing
MetricValue ( Cr)Q3 FY26Q4 FY25
Revenue3.94154.1%1085.1%
Total Income4.04149.0%197.6%
Expenditure3.93149.2%576.6%
PBT0.10143.4%86.5%
Net Profit0.11234.0%86.2%
OPM0.34%1.91pp74.47pp
NPM2.66%0.68pp54.73pp
EPS0.21320.0%85.9%
View full financials

Informational and educational content only. Not investment advice.